Ferric Citrate and Chronic Kidney Disease in Children
Phase 2
160
about 5.4 years
6–18
18 sites in CA, FL, GA +8
Why this study is shown
What this study is about
Researchers are testing whether ferric citrate (FC) can help change levels of a substance called intact FGF23 in children with chronic kidney disease. The trial will last 1962 days and involve about 160 children aged 6-18 years old, randomly assigned to either receive FC or a placebo.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Ferric Citrate
- 2.Take Placebo
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
ferric citrate
oral (Oral Tablet)
Primary: Tolerability of Ferric Citrate
Renal